We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.00 | 0.67% | 1,650.50 | 1,650.00 | 1,650.50 | 1,656.00 | 1,644.50 | 1,650.50 | 727,185 | 11:51:13 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.77 | 67.87B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 4373Y
GlaxoSmithKline PLC
08 May 2019
GlaxoSmithKline plc
Result of Annual General Meeting and General Meeting
GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') and General Meeting today, all resolutions were passed by shareholders. The full text of the resolutions considered are contained in the 2019 Notice of AGM and the sole resolution of the General Meeting is contained in the Circular to Shareholders and Notice of General Meeting. These documents are available on the GSK website at www.gsk.com.
GSK AGM Poll Results
The following table shows the total number of votes cast for each resolution:
Hot Features
Premium
Resolution Total votes % Total votes % Total votes Votes withheld(**)
for(*) against cast
Receive and adopt
the 2018 Annual
1 Report 3,556,826,649 99.95 1,863,433 0.05 3,558,690,082 7,283,024
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Approve the Annual
2 report on remuneration 3,157,857,593 88.77 399,443,579 11.23 3,557,301,172 8,672,905
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Election of Iain
3 Mackay 3,509,580,387 98.56 51,394,236 1.44 3,560,974,623 4,999,291
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
4 Philip Hampton 3,523,220,874 98.94 37,814,132 1.06 3,561,035,006 4,939,054
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
5 Emma Walmsley 3,543,610,930 99.50 17,645,007 0.50 3,561,255,937 4,724,016
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
6 Vindi Banga 3,520,241,639 98.87 40,257,748 1.13 3,560,499,387 5,474,256
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
7 Dr Hal Barron 3,542,101,484 99.46 19,107,976 0.54 3,561,209,460 4,763,464
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
8 Dr Vivienne Cox 3,494,225,537 98.85 40,751,267 1.15 3,534,976,804 30,997,813
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
9 Lynn Elsenhans 3,543,230,972 99.50 17,848,986 0.50 3,561,079,958 4,893,685
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Election of Dr
10 Laurie Glimcher 3,543,924,853 99.52 17,255,115 0.48 3,561,179,968 4,793,241
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
11 Dr Jesse Goodman 3,543,465,739 99.50 17,643,172 0.50 3,561,108,911 4,864,732
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
12 Judy Lewent 3,513,131,684 98.66 47,693,254 1.34 3,560,824,938 5,154,954
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-election of
13 Urs Rohner 3,434,585,693 96.46 126,031,133 3.54 3,560,616,826 5,356,667
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Re-appointment
14 the auditor 3,557,236,743 99.88 4,327,420 0.12 3,561,564,163 4,412,192
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Remuneration of
15 auditor 3,554,992,184 99.83 6,020,952 0.17 3,561,013,136 4,948,179
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Authority for the
company to make
donations to political
organisations and
incur political
16 expenditure 3,471,514,277 98.00 70,681,915 2.00 3,542,196,192 23,791,786
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Authority to allot
17 shares 3,444,525,603 96.77 114,953,481 3.23 3,559,479,084 6,482,169
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Disapplication
of pre-emption
rights - general
18 power(***) 3,480,629,187 97.84 76,741,126 2.16 3,557,370,313 8,607,071
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Disapplication
of pre-emption
rights - in connection
with an acquisition
or specified capital
19 investment(***) 3,390,801,857 95.31 166,798,143 4.69 3,557,600,000 8,370,163
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Authority for the
company to purchase
20 its own shares(***) 3,509,141,893 98.57 50,794,321 1.43 3,559,936,214 6,028,543
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Exemption from
statement of senior
statutory auditor's
21 name 3,524,087,916 99.51 17,395,554 0.49 3,541,483,470 24,488,266
------------------------ -------------- ------ ------------ ------ -------------- -------------------
Authority for reduced
notice of a general
meeting other than
22 an AGM(***) 3,271,677,728 92.38 269,908,346 7.62 3,541,586,074 24,387,840
------------------------ -------------- ------ ------------ ------ -------------- -------------------
GSK General Meeting Poll Results
The following table shows the total number of votes cast for the resolution:
Resolution Total votes % Total votes % Total votes Votes withheld(**)
for(*) against cast
To approve the transaction
between GlaxoSmithKline
plc, GlaxoSmithKline
Consumer Healthcare
Holdings Limited
and Pfizer, Inc for
the purposes of Chapter
11 of the Listing
Rules of the Financial
1 Conduct Authority 3,496,633,023 99.85 5,302,329 0.15 3,501,935,352 24,272,073
--------------------------- -------------- ------ ------------ ----- -------------- -------------------
Notes:
* Includes discretionary votes. In line with the notification issued
to American Depositary Receipt (ADR) holders earlier this year,
GSK did not instruct its ADR Depositary to vote any unvoted ADRs
in respect of the resolutions for the 2019 AGM and GM
** A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority.
The above poll results will shortly be available on the Company's website at www.gsk.com. In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM
Simon Dingemans did not stand for re-election as a Director and retired from the Board with effect from the conclusion of the AGM.
In accordance with section 430(2B) of the Companies Act 2006, GSK confirms that Simon Dingemans will receive payment of fees for service whilst a Director, but no other remuneration payment or payment for loss of office will be made in connection with his departure.
The following table provides further relevant information:
GSK's GSK's
Nineteenth Eighteenth
AGM AGM
(2019) (2018)
Issued share capital (excluding Treasury Shares) 4,987,806,108 4,959,302,644
-------------- --------------
Total votes cast and votes withheld lodged as
a % of GSK's issued share capital (excluding
Treasury Shares) 71.49% 78.76%
-------------- --------------
Total shareholder population 108,698 112,326
-------------- --------------
Total number of proxies lodged 6,635 6,931
-------------- --------------
% of shareholders who lodged proxies 6.10% 6.17%
-------------- --------------
Number of shareholders, corporate representatives
and proxies who attended the AGM 241 415
-------------- --------------
V A Whyte
Company Secretary
8 May 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGUGUMGAUPBGMR
(END) Dow Jones Newswires
May 08, 2019 13:23 ET (17:23 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
